Volume 3, Issue 4, August 2017, Page: 36-40
Current Profile of New HIV Infections Among Adults in Northern Benin in 2016
Cossi Angelo Attinsounon, Teaching and Research Unit of Infectious Diseases, Faculty of Medicine, University of Parakou, Parakou, Republic of Benin
Comlan Albert Dovonou, Service of Internal Medicine, CHUD of Parakou, Parakou, Republic of Benin
René Kèkè, National HIV Laboratory of Benin, Cotonou, Parakou, Republic of Benin
Cossi Adébayo Alassani, Service of Internal Medicine, CHUD of Parakou, Parakou, Republic of Benin
Kouessi Anthelme Agbodandé, Service of Internal Medicine, CNHU-HKM of Cotonou, Parakou, Republic of Benin
Finagnon Armand Wanvoegbe, Service of Internal Medicine, CNHU-HKM of Cotonou, Parakou, Republic of Benin
Angèle Kouanou-Azon, Service of Internal Medicine, CNHU-HKM of Cotonou, Parakou, Republic of Benin
Djimon Marcel Zannou, Service of Internal Medicine, CNHU-HKM of Cotonou, Parakou, Republic of Benin
Received: Aug. 11, 2017;       Accepted: Aug. 24, 2017;       Published: Sep. 26, 2017
DOI: 10.11648/j.ijhpebs.20170304.11      View  2105      Downloads  255
Abstract
Objective: The study aimed to describe the current epidemiological, clinical and immunological profile of newly detected HIV - positive patients in Northern Benin by 2016. Methods: It was a prospective study conducted from May 2 to October 31, 2016 on three main sites of care of people living with HIV (PLHIV) in the department of Borgou in Benin. All new cases of HIV infection have been systematically and comprehensively recruited. Initial epidemiological, clinical and immunological data were collected using a questionnaire. These data were entered and analyzed using the Epi Info 7 software. Results: In total, 185 adults (68 male and 117 female) newly screened HIV positive were included in this study. The middle age was 36.2 ± 10.9 years and the sex ratio was 0.6 One hundred and thirty-five patients (73%) were between 25 and 50 years old. In terms of the profession, 132 patients (71.3%) were engaged in liberal activities (craftmen, traders and retailers). The majority was schooled (113 or 61.1%) and resided in urban areas (146 or 79%). One hundred and sixteen patients lived in couple (62.7%) with an average monthly income estimated at 70 US Dollars. Clinically, 123 patients (66.5%) were in WHO stage III. The body mass index was over 18.5 kg/m2 in 124 patients (67%). The median number of TCD4 lymphocytes was 254.5 cells/ml and 25 patients (13.5%) had a number of CD4 over 500 cells/ml. HIV1 was really predominant (97.8%). Most patients (152 or 82.2%) had been screened for clinical suspicion. Conclusion: HIV infection in Benin remains the prerogative of young, female, educated and poor people. Screening is delayed and hence the need to develop innovative strategies for early HIV testing in Benin.
Keywords
Adults, HIV, New Infections, Profile, Borgou, Benin
To cite this article
Cossi Angelo Attinsounon, Comlan Albert Dovonou, René Kèkè, Cossi Adébayo Alassani, Kouessi Anthelme Agbodandé, Finagnon Armand Wanvoegbe, Angèle Kouanou-Azon, Djimon Marcel Zannou, Current Profile of New HIV Infections Among Adults in Northern Benin in 2016, International Journal of HIV/AIDS Prevention, Education and Behavioural Science. Vol. 3, No. 4, 2017, pp. 36-40. doi: 10.11648/j.ijhpebs.20170304.11
Copyright
Copyright © 2017 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Reference
[1]
ONUSIDA (2016) Global AIDS update. UNAIDS pp. 16. http://www.unaids.org/sites/default/files/media_asset/global-AIDS-update-2016_en.pdf. Consulted at 11/02/17.
[2]
Comité National de Lutte contre le SIDA (2016). Rapport de suivi de la déclaration de politique sur le VIH/SIDA au Bénin. CNLS-Bénin. pp. 22.
[3]
OMS (2013) Lignes directrices unifiées sur l’utilisation des antirétroviraux pour le traitement et la prévention de l’infection à VIH. Résumé des principales caractéristiques et recommandations. www.who.int/hiv/pub/guidelines/arv2013/15facts/fr. Consulted at 11/02/17.
[4]
Programme National de Lutte contre le Sida (2014) Politique, normes et procédures pour la prise en charge des personnes vivant avec le VIH au Bénin. PNLS-Bénin. pp. 41.
[5]
OMS (2016) Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Recommendations for a public health approach - Second edition. pp. 480. http://www.who.int/hiv/pub/arv/arv-2016/en/. Consulted at 11/02/17.
[6]
Eaton JW, Johnson LF, Salomon JA, Bärnighausen T, Bendavid E, Bershteyn A, Bloom DE, Cambiano V, Fraser C, Hontelez JA, Humair S, Klein DJ, Long EF, Phillips AN, Pretorius C, Stover J, Wenger EA, Williams BG, Hallett TB (2012) HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa. PLoS Med. 9(7): e1001245.
[7]
Govindasamy D, Meghij J, Negussi EK, Baggaley RC, Ford N, and Kranzer K (2014) Interventions to improve or facilitate linkage to or retention in pre-ART (HIV) care and initiation of ART in low- and middle-income settings – a systematic review. J Int AIDS Soc. 17(1): 19032.
[8]
Herout S, Mandorfer M, Breitenecker F, Reiberger T, Grabmeier-Pfistershammer K, Rieger A, Aichelburg MC (2016) Impact of early initiation of antiretroviral therapy in patients with acute HIV Infection in Vienna, Austria. PLoS One. 11(4): e0152910.
[9]
IeDea and ART Cohort Collaborations, Avila D, Althoff KN, Mugglin C, Wools-Kaloustian K, Koller M, Dabis F, Nash D, Gsponer T, Sungkanuparph S, McGowan C, May M, Cooper D, Chimbetete C, Wolff M, Collier A, et al. (2014) Immunodeficiency at the start of combination antiretroviral therapy in low-, middle-, and high-income countries. J Acquir Immune Defic Syndr. 65(1): e8–16.
[10]
Déguénonvo LF, Manga NM, Diop SA, Dia Badiane M, Seydi M, N’dour CT, Soumaré M, Diop BM, Sow PS (2011) Profil actuel des patients infectés par le VIH hospitalisés à Dakar (Sénégal). Bull. Soc. Pathol. Exot. 104: 366-370.
[11]
Koné MC, Cissoko Y, Diallo MS, Traoré BA, Mallé KK (2013) Données épidémiologiques, cliniques et thérapeutiques des patients infectés par le VIH sous traitement antirétroviral à l’hôpital de Ségou au Mali (2004-2011). Bull. Soc. Pathol. Exot. 106: 176-179.
[12]
Kra O, Aba YT, Ouatara B, Abouo F, Tanon KA, Eholié S, Bissagnené E (2013) Profil clinicobiologique, thérapeutique et évolutif des patients infectés par le VIH hospitalisés au service des maladies infectieuses et tropicales d’Abidjan (Côte d’Ivoire). Bull. Soc. Pathol. Exot. 106(1): 37 – 42.
[13]
Koy T, Mukumbi H, Malandala GLM, Donnen P, Wilmet–Dramaix M (2014) Profil comparatif et évolutif des personnes infectées par le virus de l’immunodéficience humaine traitées aux antirétroviraux à Kinshasa, République Démocratique du Congo. Pan African Medical Journal. 19: 388.
[14]
Nash D, Tymejczyk O, Gadisa T, Gorrell Kulkarni S, Hoffman S, Yigzaw M, Elul B, Remien RH, Lahuerta M, Daba S, El Sadr W, and Melaku Z (2016) Factors associated with initiation of antiretroviral therapy in the advanced stages of HIV infection in six Ethiopian HIV clinics, 2012 to 2013. J Int AIDS Soc. 19(1): 20637.
[15]
Daftary A, Padayatchi N (2013) Integrating patients’ perspectives into integrated TB/HIV healthcare. Int J Tuberc Lung Dis. 17(4): 546–551.
[16]
van Schalkwyk C, Variava E, Shapiro AE, Rakgokong M, Masonoke K, Lebina L, Welte A, Martinson N (2014) Incidence of TB and HIV in prospectively followed household contacts of TB index patients in South Africa. PLoS One. 9(4): e95372.
[17]
Nsagha DS, Njunda AL, Assob NJC, Ayima CW, Tanue EA, Kibu OD, Kwenti TE (2016) Intestinal parasitic infections in relation to CD4+ T cell counts and diarrhea in HIV/AIDS patients with or without antiretroviral therapy in Cameroon. BMC Infect Dis. 16: 9.
[18]
Kerschberger B, Hilderbrand K, Boulle AM, Coetzee D, Goemaere E, De Azevedo V, Van Cutsem G (2012) The effect of complete integration of HIV and TB services on time to initiation of antiretroviral therapy: a before-after study. PLoS One. 7(10): e46988.
[19]
Rie AV, Clouse K, Hanrahan C, Selibas K, Sanne I, Williams S, Kim P, Bassett J (2014) High uptake of systematic HIV counseling and testing and TB symptom screening at a primary care clinic in South Africa. PLoS One 9(9): e105428.
Browse journals by subject